North America Microelectrode Array In Vitro Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

No. of Pages: 101    |    Report Code: BMIRE00032080    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Microelectrode Array In Vitro Market

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

3.3 Assumptions and Limitations

4. North America Microelectrode Array in Vitro Market Landscape

4.1 PEST Analysis

5. North America Microelectrode Array in Vitro Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Demand for Microelectrode Arrays in Neuroscience Research

5.1.2 Rising Focus on Developing Alternatives for Animal Testing Models

5.2 Market Restraints

5.2.1 High Development Costs of Microelectrode Arrays

5.3 Market Opportunities

5.3.1 Microelectrode Arrays with Advanced Features

5.4 Future Trends

5.4.1 Integration of Microelectrode Array Technologies with Organ-On-A-Chip

5.5 Impact of Drivers and Restraints:

6. Microelectrode Array in Vitro Market - North America Analysis

6.1 North America Microelectrode Array in Vitro Market Revenue (US$ Thousand), 2021-2031

6.2 North America Microelectrode Array in Vitro Market Forecast Analysis

7. North America Microelectrode Array in Vitro Market Analysis - by Product

7.1 Classical MEA

7.1.1 Overview

7.1.2 Classical MEA: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

7.2 Multiwell-MEA

7.2.1 Overview

7.2.2 Multiwell-MEA: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

7.3 CMOS-MEA

7.3.1 Overview

7.3.2 CMOS-MEA: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8. North America Microelectrode Array in Vitro Market Analysis - by Application

8.1 Cardiomyocytes

8.1.1 Overview

8.1.2 Cardiomyocytes: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8.2 Nerve

8.2.1 Overview

8.2.2 Nerve: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8.3 Others

8.3.1 Overview

8.3.2 Others: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9. North America Microelectrode Array in Vitro Market - Country Analysis

9.1 North America

9.1.1 North America Microelectrode Array in Vitro Market - Revenue and Forecast Analysis - by Country

9.1.1.1 North America Microelectrode Array in Vitro Market - Revenue and Forecast Analysis - by Country

9.1.1.2 United States: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.2.1 United States: North America Microelectrode Array in Vitro Market Share - by Product

9.1.1.2.2 United States: North America Microelectrode Array in Vitro Market Share - by Application

9.1.1.3 Canada: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.3.1 Canada: North America Microelectrode Array in Vitro Market Share - by Product

9.1.1.3.2 Canada: North America Microelectrode Array in Vitro Market Share - by Application

9.1.1.4 Mexico: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9.1.1.4.1 Mexico: North America Microelectrode Array in Vitro Market Share - by Product

9.1.1.4.2 Mexico: North America Microelectrode Array in Vitro Market Share - by Application

10. Microelectrode Array in Vitro Market - Industry Landscape

10.1 Overview

11. Company Profiles

11.1 Tucker Davis Technologies

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 SCREEN Holdings Co., Ltd.

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Plexon Inc.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 MaxWell Biosystems AG

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Harvard Bioscience Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Axion BioSystems Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 3Brain AG

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 NeuroNexus Technologies Inc.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 MicroElectrodeDevices

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Blackrock Microsystems, Inc.

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

11.11 NMI Technologietransfer GmbH

11.11.1 Key Facts

11.11.2 Business Description

11.11.3 Products and Services

11.11.4 Financial Overview

11.11.5 SWOT Analysis

11.11.6 Key Developments

11.12 BMSEED

11.12.1 Key Facts

11.12.2 Business Description

11.12.3 Products and Services

11.12.4 Financial Overview

11.12.5 SWOT Analysis

11.12.6 Key Developments

12. Appendix

12.1 Glossary of Terms

12.2 About The Insight Partners

 

List of Tables

Table 1. North America Microelectrode Array in Vitro Market Segmentation

Table 2. North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Table 3. North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Product

Table 4. North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Application

Table 5. North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Country

Table 6. United States: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 7. United States: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Application

Table 8. Canada: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 9. Canada: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Application

Table 10. Mexico: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Product

Table 11. Mexico: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Application

Table 12. Recent Growth Strategies in Microelectrode Array in Vitro Market

Table 13. Glossary of Terms, Microelectrode Array in Vitro Market

List of Figures

Figure 1. North America Microelectrode Array in Vitro Market Segmentation - Country

Figure 2. PEST Analysis

Figure 3. North America Microelectrode Array in Vitro Market - Key Market Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. North America Microelectrode Array in Vitro Market Revenue (US$ Thousand), 2021-2031

Figure 6. North America Microelectrode Array in Vitro Market Share (%) - by Product (2023 and 2031)

Figure 7. Classical MEA: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 8. Multiwell-MEA: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 9. CMOS-MEA: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 10. North America Microelectrode Array in Vitro Market Share (%) - by Application (2023 and 2031)

Figure 11. Cardiomyocytes: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 12. Nerve: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 13. Others: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

Figure 14. North America Microelectrode Array in Vitro Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 15. United States: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 16. Canada: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

Figure 17. Mexico: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)

 

The List of Companies - North America Microelectrode Array In Vitro Market

  • Tucker Davis Technologies
  • SCREEN Holdings Co., Ltd.
  • Plexon Inc.
  • MaxWell Biosystems AG
  • Harvard Bioscience Inc.
  • Axion BioSystems Inc
  • 3Brain AG
  • NeuroNexus Technologies Inc.
  • MicroElectrodeDevices
  • Blackrock Microsystems, Inc.
  • NMI Technologietransfer GmbH
  • BMSEED